Skip to main content

Les Zulesky

Analyst

Oppenheimer

Equibles does not estimate personal net worth.

About Les Zulesky

Les Zulesky is recorded as Analyst at Oppenheimer. Les Zulesky has spoken on 1 investor event across 1 company, most recently for PolyPid Ltd. on October 28, 2026. The companies whose calls Les Zulesky spoke on are classified in the Healthcare sector.

Les Zulesky on recent calls

“First, for Dr. Joseph, where would a local antibiotic such as OB1 fit within the treatment setting, inpatient, outpatient, or podiatry office? And then secondly, on formulation, do you see this as a physician or patient-administered product?”
Analyst — Oppenheimer, PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026 ·

Affiliation history

  • Oppenheimer

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity